Meeting addresses limits of state regulation and alternatives to expand access to treatments

New service at Case will serve People with aggressive behavior in ASD, using cannabidiol for the first time and registered in Nate

PL 569/2021, which provides for the supply of cannabidiol-based medications in public and affiliated units, has a favorable opinion in the Health Committee

New regulation could make the country a reference in the sector by 2026

New legislation regulates production, tracking, and distribution of low-THC products for therapeutic use

New technique uses centrifugal partition chromatography and achieves 85% CBD in a product with only 0.02% THC

General coordinator details the efforts made by the public agency

Bedrocan has started distributing its most potent medicinal cannabis flower in Germany, with 25% THC, expanding the options available in the country's regulated market

The Sechat Portal spoke with Courier Brasil Express to address the main questions patients have regarding the importation of medications.

Partnership includes two products authorized by Anvisa

Combining health and flavor, mushroom-infused coffee attracts consumers seeking energy and well-being

Prohibition costs R$ 51 billion annually and contributes to the incarceration of Black and poor populations, highlights report

Participation in the Medical Cannabis Fair 2024 marks a new chapter in the company's history

Porto Alegre's Health Secretary holds a meeting with representatives of the agenda and defines next steps to distribute medications through the Unified Health System (SUS), Legislative Assembly awaits a report from a deputy to advance discussions on cannabis

Decree No. 4,977 published in the Official Gazette establishes guidelines for provision by the State Health agencies

Judge Vera Lúcia Feil's injunction orders the release of the company's cannabidiol after facing automatic denials from the regulatory agency

Pharmaceutical Assistance Coordination evaluates proposals in a public session. The announcement of the winning company is expected in 2023, subject to appeals and disqualifications.

“There are about 4000 valid HCs currently,” says lawyer Emílio Figueiredo as he explores the benefits and challenges of patients' journey towards therapeutic autonomy.

State deputies present proposal to offer therapeutic treatment based on cannabidiol to patients in vulnerable situations

The Bill provides for the distribution of cannabis-based medicines through the SUS of the State of São Paulo